U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [x} Form N-SAR
For Period Ended: September 30, 1995
Part 1 - Registrant Information
- -------------------------------
Full Name of Registrant: Hygenics Pharmaceuticals, Inc.
Former Name if Applicable:
Brian Pharmaceuticals, Inc.
Address of Principal Executive Office:
26012 Margarite Parkway #H132
City, State and Zip Code:
Mission Viejo, CA 92691
Part II - Rules 12b-25 (b) and (c)
- --------------------------------
if the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
x (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense.
Part III - Narrative
- --------------------
State below in reasonable detail the reasons why Form 10-K, 20-F 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed within
the prescribed time period.
The Accountants were unable to complete accurate financial statements.
Part IV - Other Information
- ---------------------------
(1) Name and telephone number of person to contact in regard to this
notification:
William Goedecke 714-582-7644
- ------------------------------------------------------------
(Name) (Area Code) (Telephone No.)
(2) have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the answer
is no, identify report(s).
[x]yes [ ]no
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof?
[ ]yes [x]no
Hygenics Pharmaceuticals, Inc.
------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: 11/11/96 By: /s/ William Goedecke
